BNT162b2 mRNA COVID-19 Vaccine Does Not Impact the Honeymoon Phase in Type 1 Diabetes: A Case Report

BNT162b2 mRNA COVID-19 Vaccine Does Not Impact the Honeymoon Phase in Type 1 Diabetes: A Case Report

Type 1 diabetes (T1D), which is caused by the autoimmune destruction of insulin-secreting pancreatic beta cells, represents a high-risk category requiring COVID-19 vaccine prioritization. Although COVID-19 vaccination can lead to transient hyperglycemia (vaccination-induced hyperglycemia; ViHG), its...

Full description

Bibliographic Details
Main Authors: Marco Infante, Andrea Fabbri, Nathalia Padilla, Francesca Pacifici, Pasquale Di Perna, Laura Vitiello, Alessandra Feraco, Maria Giuliano, Marina Passeri, Massimiliano Caprio, Camillo Ricordi, David Della-Morte, Luigi Uccioli
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Vaccines
Subjects:
T1D
honeymoon phase
clinical remission
autoimmunity
hyperglycemia
beta cell
Online Access:https://www.mdpi.com/2076-393X/10/7/1096

Internet

https://www.mdpi.com/2076-393X/10/7/1096

Similar Items